Scm Lifescience

Stem cell therapeutics and related services

placeIncheon, Incheon, South Korea calendar_todayFounded 2014 groups53 employees language scmlifescience.com

Innovation

27 patent families (14 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 401 times.

YearFilings
20162
20172
20185
20197
20209
20217
202211
20238
20249
202510

Investor mix

7 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital343%
Private equity229%
Bank & private debt114%
Other / undisclosed114%
Coming soon